MTOR and plasma cell myeloma: Inhibition of IL-6 mediated signaling by decreasing the expression of its receptor at the transcription level via AMPK, mTOR, and miR-34a is one of the newer mechanisms that suggest metformin as a potential treatment for multiple myeloma [64].